Optiver Holding
VIR icon

Optiver Holding’s Vir Biotechnology VIR Stock Holding History

Optiver Holding’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.82K Buy
+473
New +$4.5K ﹤0.01% 2004
2025
Q4 		– Sell
-456
Closed -$2.6K – 3034
2025
Q3 		$2.6K Buy
+456
New +$2.33K ﹤0.01% 2263

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Optiver Holding's VIR Position: Q2 2026 in Review

Optiver Holding opened a new position in Vir Biotechnology (VIR) in Q2 2026: 473 shares worth $4.82K. The stake represents ﹤0.01% of the portfolio and ranks #2004 among its holdings. This is a return to the name: Optiver Holding previously reported a position in VIR as recently as Q3 2025.

Optiver Holding first reported a position in VIR in Q3 2025 and has held it in 2 quarters since. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Optiver Holding held 473 shares of Vir Biotechnology worth $4.82K as of Q2 2026.
  • Vir Biotechnology was a new Optiver Holding position in Q2 2026.
  • Vir Biotechnology made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2004 holding.
  • Optiver Holding first reported a position in Vir Biotechnology in Q3 2025 and has held it in 2 quarters since.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.